Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
On Target Laboratories logo — Our mission is to illuminate cancer intraoperatively so it c...

On Target Laboratories

Our mission is to illuminate cancer intraoperatively so it can be removed completely.

Founded 2010 United States West Lafayette, United States 45 employees Series C Total: $111.70M Biotechnology, Life Sciences

General Information

Company Name On Target Laboratories
Founded Year 2010
Location United States West Lafayette, United States +1
Employees 45
Industries Biotechnology, Life Sciences
Funding Stage Series C
Social

Get notified when On Target Laboratories moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About On Target Laboratories

On Target Laboratories is a biotechnology startup founded in 2010 with a mission to illuminate cancer intraoperatively for more complete removal. The company's molecular imaging agents are designed to assist surgeons in identifying and removing cancerous tissue with greater precision. Leveraging the groundbreaking work of Philip S. Low, PhD, the technology aims to address the existing uncertainty in cancer resection during surgical procedures.

The latest significant milestone for On Target Laboratories was a $30.00M Series C investment on 16 November 2023. The investment was led by a consortium of prominent investors including Elevate Ventures, Johnson & Johnson Innovation, 3B Future Health Fund, H.I.G. Capital, Olympus Corporation of the Americas, and the Pension Fund of the Christian Church. This funding is indicative of the confidence and support the startup has garnered from a diverse group of strategic investors.

On Target Laboratories' focus on innovation and its potential to revolutionize cancer surgery aligns with the interests of investors seeking impactful healthcare technologies. With its headquarters in the United States, the company is well-positioned to further advance its mission and leverage the recent investment to drive its groundbreaking technology to new heights in the fight against cancer.

Taxonomy: cancer detection, molecular imaging, surgical resection, oncology technology, surgical precision, cancer research, intraoperative imaging, targeted therapy, oncological surgery, medical innovation

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 6
Investor Investor Investor
•••• •••• 		16 Nov 2023
Series B •••••• 4
Investor Investor Investor
•••• •••• 		24 Mar 2021
Series B •••••• 3
Investor Investor Investor
14 Mar 2018
Series B •••••• 1 •••• •••• 02 Nov 2017
Venture Round •••••• 1 •••• •••• 04 May 2015

View All 6 Funding Rounds

On Target Laboratories Alternatives & Competitors

On Target Laboratories vs
Vergent Bioscience
Vergent Bioscience

Illuminate the path to precise cancer surgery with advanced imaging that distinguishes tumor tissue...

Series B
2-10 employees
Biotechnology, Health Care
Compare On Target Laboratories vs Vergent Bioscience
On Target Laboratories vs
Edinburgh Molecular Imaging Ltd
Edinburgh Molecular Imaging Ltd United Kingdom

Founded in 2014, Edinburgh Molecular Imaging (EM Imaging) is a clinical phase biotechnology company...

Series Unknown
6 employees
Biotechnology, Health Care
Compare On Target Laboratories vs Edinburgh Molecular Imaging Ltd
On Target Laboratories vs
NUTEK- Insight beyond the visible
NUTEK- Insight beyond the visible Austria

We develop innovative systems that ensure complete cancerous tissue removal before closing, reducing...

6 employees
Health Care
Also compare with: On Target Laboratories vs Clarix Imaging Clarix Imaging On Target Laboratories vs OncoRes Medical OncoRes Medical

FAQ About On Target Laboratories

Our mission is to illuminate cancer intraoperatively so it can be removed completely.
On Target Laboratories was founded in 2010.
On Target Laboratories is headquartered in West Lafayette, United States.
On Target Laboratories operates in the following industries: Biotechnology, Life Sciences.
On Target Laboratories has approximately 45 employees.
On Target Laboratories has completed 6 funding rounds, raising a total of $111.70M. The latest funding stage is Series C.
Top alternatives and competitors to On Target Laboratories include Vergent Bioscience, Edinburgh Molecular Imaging Ltd, NUTEK- Insight beyond the visible, Clarix Imaging, Imagin Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
On Target Laboratories and Vergent Bioscience are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors On Target Laboratories and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy